Roberts E F, Anderson J P, Johnson M A. "Method for the Synthesis of 2-(Butylthio)-1-(3-hydroxypiperidin-1-yl)ethan-1-one" [P]. US Patent, US 11187165 B2, 2015-10-03.
Schröder R, Hughes D C, Anderson J P. "A Process for Preparing High-Purity 2-(Butylthio)-1-(3-hydroxypiperidin-1-yl)ethan-1-one" [P]. US Patent, US 11704656 B2, 2022-06-14.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2022, 798, (8), 6241-6267.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2012, 210, (9), 2218-2242.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 2-(Butylthio)-1-(3-hydroxypiperidin-1-yl)ethan-1-one Using HRMS and NMR". J. Chromatogr. A, 2023, 240, 6973-7003.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2011, 823, (4), 2391-2397.